247 patients (mean age 14.3±7.6 years) were enrolled from study sites in North America, Europe, and Australia, with a median fenfluramine exposure of 364 days (range: 19–537) and a mean daily dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback